1.Relationship between Bone Mineral Density, Erythropoiesis, and Calcium-Phosphorus-Parathyroid Hormone Status in End-stage Renal Disease Patients.
Yoon ju OH ; Seongbin HONG ; Kyungsun MIN ; Joon Ho SONG ; Seung Youn LEE ; So Hun KIM ; Moonsuk NAM ; Yong Seong KIM
Korean Journal of Bone Metabolism 2011;18(2):93-99
OBJECTIVES: Abnormal bone turnover and mineralization is the characteristic of the end-stage renal disease (ESRD) patients receiving dialysis treatment. Reduced bone mineral density (BMD) has been reported in ESRD patients in many recent studies. Recent study has demonstrated hypoxia increases the loss of bone mass whereas the use of erythropoietin (EPO) increases bone marrow mesenchymal stem cell in vitro, which is the commonly found in ESRD patients. The objective of the present study is to analyze the relationship between erythropoiesis and calcium, phosphorus, parathyroid hormone (PTH) status in ESRD patients. METHODS: This study was a cross-sectional analysis of 183 ESRD patients (78 males, 105 females) on dialysis with mean age of 52 +/- 13 years and mean dialysis duration of 3.4 +/- 3.0 years. Duration and dose of EPO administration, hemoglobin, serum ferritin, and iron were checked in all subjects. BMD was evaluated by DXA. RESULTS: Age was negatively, and body weight and c-calcium positively associated with spine and femur neck and total hip BMD. Hemoglobin was positively correlated with femur neck and total hip BMD. Total dose of EPO, iPTH, and alkaline phosphatase had no significant association with BMD. However, according to tertile of serum PTH concentration, BMD were worst in third tertile group. In multivariate linear regression analysis, age, weight, and serum PTH affect BMD. CONCLUSIONS: BMD was independently related with age and weight. Hemoglobin correlated positively with femur neck and total hip BMD. However, treatment with EPO had no association with BMD. Increased PTH was related with reduced BMD.
Alkaline Phosphatase
;
Anoxia
;
Body Weight
;
Bone Density
;
Bone Marrow
;
Calcium
;
Cross-Sectional Studies
;
Dialysis
;
Erythropoiesis
;
Erythropoietin
;
Femur Neck
;
Ferritins
;
Hemoglobins
;
Hip
;
Humans
;
Iron
;
Kidney Failure, Chronic
;
Linear Models
;
Male
;
Mesenchymal Stromal Cells
;
Parathyroid Hormone
;
Phosphorus
;
Spine
2.Atypical Subtrochanteric and Diaphyseal Femoral Fractures.
Kyu Hyun YANG ; Hyung Keun SONG
Korean Journal of Bone Metabolism 2011;18(2):85-92
Increasing numbers of atypical subtrochanteric fractures have been reported among long-term bisphosphonate users. However, the nature and extent of the problem are unknown despite recent investigations. The task force of American Society for Bone and Mineral Research (ASBMR) defined major and minor features of complete and incomplete atypical femoral fractures; transverse or short oblique orientation, minimal or no associated trauma, a medial spike when the fracture is complete, and absence of comminution. Minor features include their association with cortical thickening, a periosteal reaction of the lateral cortex, prodromal pain, bilaterality, delayed healing, comorbid conditions, and concomitant drug exposures, including bisphosphonate, glucocorticoids, and proton pump inhibitors. Based on published data, the incidence of atypical femoral fractures associated with bisphosphonate therapy for osteoporosis appears to be very low, particularly compared with the number of vertebral, hip, and other fractures that are prevented by bisphosphonate. Physicians and patients should be aware of the possibility of atypical femoral fractures and of the potential for bilaterality.
Advisory Committees
;
Diphosphonates
;
Femoral Fractures
;
Glucocorticoids
;
Hip
;
Hip Fractures
;
Humans
;
Incidence
;
Orientation
;
Osteoporosis
;
Proton Pump Inhibitors
3.High Dietary Sodium Intake Assessed by 24-hour Urine Specimen Increase Urinary Calcium Excretion and Bone Resorption Marker.
Sun Mi PARK ; Jaehwan JEE ; Ji Young JOUNG ; Yoon Young CHO ; Seo Young SOHN ; Sang Man JIN ; Kyu Yeon HUR ; Jae Hyeon KIM ; Sun Wook KIM ; Jae Hoon CHUNG ; Moon Kyu LEE ; Yong Ki MIN
Journal of Bone Metabolism 2014;21(3):189-194
BACKGROUND: The average dietary sodium intake of Koreans is 2.6 times higher than the World Health Organization's recommended amount. The effect of a diet high in sodium on the skeletal system, especially osteoporosis, has not previously been examined in Korean postmenopausal women with low bone mass. We assessed the daily sodium intake, and determined the impact of sodium intake on urinary calcium excretion and bone resorption marker. METHODS: A retrospective review of medical records was performed for 86 postmenopausal subjects who were initially diagnosed with osteopenia or osteoporosis at the health promotion center. They were subsequently referred to the Division of Endocrinology and Metabolism between 2010 and 2013. All subjects completed a modified food frequency questionnaire. Twenty-four hour urine collection for sodium, calcium and creatinine excretion, and serum C-terminal telopeptides of type I collagen (CTX-I) were also obtained. RESULTS: The average amount of daily sodium and calcium intake were 3,466 mg and 813 mg, respectively. Average dietary sodium intake and 24-hour urinary sodium excretion showed significant positive linear correlation (r=0.29, P=0.006). There was also a significant positive linear correlation between 24-hour urine sodium and calcium excretion (r=0.42, P<0.001); CTX-I and 24-hour urinary calcium excretion (r=0.29, P=0.007). CONCLUSIONS: Excessive sodium intake assessed by 24-hour urine specimen is associated with high calcium excretion in urine. High calcium excretion is also related to increasing bone resorption marker.
Bone Diseases, Metabolic
;
Bone Resorption*
;
Calcium*
;
Collagen Type I
;
Creatinine
;
Diet
;
Endocrinology
;
Female
;
Health Promotion
;
Humans
;
Medical Records
;
Metabolism
;
Osteoporosis
;
Retrospective Studies
;
Sodium
;
Sodium, Dietary*
;
Urine Specimen Collection
;
World Health
;
World Health Organization
;
Surveys and Questionnaires
4.Microarray Analysis of Gene Expression Reveals that Cyclo-oxygenase-2 Gene Therapy Up-regulates Hematopoiesis and Down-regulates Inflammation During Endochondral Bone Fracture Healing.
K H William LAU ; Nicoleta L POPA ; Charles H RUNDLE
Journal of Bone Metabolism 2014;21(3):169-188
BACKGROUND: Cyclo-oxygenase-2 (Cox-2) is an inflammatory mediator that is necessary for the tissue repair, including bone fracture healing. Although the application of Cox-2 gene therapy to a murine closed femoral fracture has accelerated bony union, but the beneficial effect was not observed until the endochondral stage of bone repair that is well after the inflammatory stage normally subsides. METHODS: To identify the molecular pathways through which Cox-2 regulates fracture healing, we examined gene expression profile in fracture tissues in response to Cox-2 gene therapy during the endochondral bone repair phase. Cox-2 gene therapy was applied to the closed murine femur fracture model. Microarray analysis was performed at 10 days post-fracture to examine global gene expression profile in the fracture tissues during the endochondral bone repair phase. The entire repertoire of significantly expressed genes was examined by gene set enrichment analysis, and the most up-regulated individual genes were evaluated further. RESULTS: The genes that normally promote inflammation were under-represented in the microarray analysis, and the expression of several inflammatory chemokines was significantly down-regulated. There was an up-regulation of two key transcription factor genes that regulate hematopoiesis and erythropoiesis. More surprisingly, there was no significant up-regulation in the genes that are normally involved in angiogenesis or bone formation. However, the expression of two tissue remodeling genes was up-regulated. CONCLUSIONS: The down-regulation of the inflammatory genes in response to Cox-2 gene therapy was unexpected, given the pro-inflammatory role of prostaglandins. Cox-2 gene therapy could promote bony union through hematopoietic precursor proliferation during endochondral bone repair and thereby enhances subsequently fracture callus remodeling that leads to bony union of the fracture gap.
Bony Callus
;
Chemokines
;
Cyclooxygenase 2
;
Down-Regulation
;
Erythropoiesis
;
Femoral Fractures
;
Femur
;
Fracture Healing
;
Fractures, Bone*
;
Gene Expression*
;
Genetic Therapy*
;
Hematopoiesis*
;
Inflammation*
;
Microarray Analysis*
;
Osteogenesis
;
Prostaglandins
;
Transcription Factors
;
Transcriptome
;
Up-Regulation
5.Factors and Mechanisms Involved in the Coupling from Bone Resorption to Formation: How Osteoclasts Talk to Osteoblasts.
Journal of Bone Metabolism 2014;21(3):163-167
Bone remodeling is the fundamental means by which the quality as well as quantity of the skeleton is maintained throughout adult life. When bone remodeling goes awry, a metabolic bone disease such as osteoporosis ensues. Among multiple phases of the complex remodeling process, we focus in this review on factors and mechanisms that are involved in the coupling of bone formation to preceding resorption.
Adult
;
Bone Diseases, Metabolic
;
Bone Remodeling
;
Bone Resorption*
;
Humans
;
Osteoblasts*
;
Osteoclasts*
;
Osteogenesis
;
Osteoporosis
;
Skeleton
6.Erratum to: Vitamin D Deficiency Is Highly Concomitant but Not Strong Risk Factor for Mortality in Patients Aged 50 Year and Older with Hip Fracture.
Kyung Hag LEE ; Jung Won LIM ; Yong Gum PARK ; Yong Chan HA
Journal of Bone Metabolism 2016;23(1):49-49
In this article, The author's name and Table 1 should be corrected.
7.Calcaneal Insufficiency Fracture after Ipsilateral Total Knee Arthroplasty.
Min JEONG ; Jin Woo JIN ; Sung Jin SHIN ; Byoung Youl KANG
Journal of Bone Metabolism 2016;23(1):45-48
Insufficiency fracture of the calcaneus is a rare entity. In the absence of trauma, evaluating a painful ankle in an elderly patient can be difficult and also it might be overlook the insufficiency fracture. We experienced a case of insufficiency calcaneus fracture that occurred after ipsilateral total knee arthroplasty. Here, we report our case with a review of literatures.
Aged
;
Ankle
;
Arthroplasty*
;
Calcaneus
;
Fractures, Stress*
;
Humans
;
Knee*
8.Sequential Bilateral Insufficiency Fractures of the Femur Neck in Patients Treated with Prolonged Bisphosphonate Therapy: A Case Report.
Chung Hee OH ; Kyung Won CHOI ; Ji Hoon BAEK ; Yong Chan HA ; Soo Yong KANG
Korean Journal of Bone Metabolism 2011;18(1):65-68
The relationship between long-term bisphosphonate usage and insufficiency fracture in osteoporotic elderly patients has been increased interest in recent years. Most reported insufficiency fractures are predominantly concentrated on proximal femoral shaft or pelvic bone. However, there was no report about insufficiency femoral neck fracture after long term use of bisphosphonate in domestic. We experienced a rare case of a 70-years-old woman who was diagnosed with bilateral insufficiency femoral neck fracture after 8 years use of alendronate. We performed an internal fixation using 6.5 mm diameter cannulated screws for the both insufficiency femoral neck fracture. Symptoms disappeared immediately after the surgery and there was no radiologic and clinical complication such as nonunion or delayed union up to the latest follow-up at 12 months postoperatively.
Aged
;
Alendronate
;
Female
;
Femoral Neck Fractures
;
Femur
;
Femur Neck
;
Follow-Up Studies
;
Fractures, Stress
;
Humans
;
Pelvic Bones
9.The Association between Components of the Metabolic Syndrome and Bone Mineral Density.
Jin Sung YUK ; Geum Joon CHO ; Chan Hee JIN ; Kyong Wook YI ; Tak KIM ; Jun Young HUR ; Sun Haeng KIM ; Jung Ho SHIN
Korean Journal of Bone Metabolism 2011;18(1):55-64
OBJECTIVE: The aim of this study was to evaluate the association between the components of the metabolic syndrome (MS) and bone mineral density (BMD). METHODS: We conducted a retrospective cross-sectional analysis for 128 men (mean age 50.4 +/- 8.3 years) and 391 women (mean age 46.9 +/- 11.6 years) in Korea University Guro Hospital, Korea. Height (cm), weight (kg), waist circumference (cm), and blood pressure (mmHg) were measured. Fasting plasma glucose (FPG), high-density lipoprotein cholesterol (HDL-C), and triglycerides were measured. BMD at the total hip and lumbar spine was measured by dual X-ray densitometry. All participants completed a standardized questionnaire including medical history, smoking history, alcohol consumption, physical activity and menopausal status. RESULTS: Women with MS had lower BMD at lumbar and total hip sites (0.937 +/- 0.136 g/cm2, P-value 0.010; 0.875 +/- 0.113 g/cm2, P-value 0.045, respectively) than did women without MS. These differences at the spine and femoral neck were persisted after adjusting for age, body mass index, menopause status, alcohol consumption, smoking and physical activity. However, no significant differences in BMD were found in men between those with and without MS. In linear regression analyses, waist circumferences were highly associated with BMD at lumbar and total hip sites in women (beta -0.003, P-value < 0.001; beta -0.001, P-value 0.001, respectively). However, no significant differences were found in men between BMD and components of the MS. CONCLUSION: Among components of MS, waist circumference was associated with BMD in women. But no association was found in men. Women with MS had lower BMD than did women without MS.
Absorptiometry, Photon
;
Alcohol Drinking
;
Blood Pressure
;
Body Mass Index
;
Bone Density
;
Cholesterol
;
Cross-Sectional Studies
;
Fasting
;
Female
;
Femur Neck
;
Glucose
;
Hip
;
Humans
;
Korea
;
Linear Models
;
Lipoproteins
;
Male
;
Menopause
;
Motor Activity
;
Osteoporosis
;
Plasma
;
Retrospective Studies
;
Smoke
;
Smoking
;
Spine
;
Triglycerides
;
Waist Circumference
;
Surveys and Questionnaires
10.Could Prior Oral-bisphosphonate Administration Reduce the Acute Phase Reaction of Zoledronate?.
Sung Hwa SEO ; Hwan Seong CHO ; Sang Ho CHEON ; Hye mi JEONG ; Il Hyung PARK
Korean Journal of Bone Metabolism 2011;18(1):49-54
OBJECTIVE: Bisphosphonates are the most commonly prescribed medications for the treatment of osteoporosis. This study was designed to analyze the rate of acute phase reaction (APR) following Zoledronate 5 mg administration in patients with osteoporosis who were treated with prior oral bisphosphonate for at least 2 weeks and to compare naive IV 5 mg Zoledronate. METHODS: Between July 2009 and October 2010, 27 patients with osteoporosis who were treated with prior oral bisphosphonate for at least 2 weeks, and maximum 52 weeks (average 18.5 weeks) and were between 42-and 85-year-old at the time of study participation. We prospectively evaluated APR, including fever, flu-like symptoms, headache, arthralgia, and myalgia, after 5 mg zoledronate by questionnaire. Additionally we assessed a visual analogue scale (VAS) by 4-point categorical scale. RESULTS: In this study of 27 patients with osteoporosis, the frequency of APR, flu-like symptom and myalgia were 14.8% and 7.4% and fever, arthralgia, and headache were 3.7% respectively. In VAS, all reactions were mild. The rate of APR rate in this study was statistically decreased compared to previous reports with zoledronate 5 mg IV in bisphosphonate-naive patients. CONCLUSION: Prior oral bisphosphonate administration for at least 2 weeks could significantly reduce the APR of IV zoledronate 5 mg.
Acute-Phase Reaction
;
Aged, 80 and over
;
Arthralgia
;
Diphosphonates
;
Fever
;
Headache
;
Humans
;
Imidazoles
;
Osteoporosis
;
Prospective Studies
;
Surveys and Questionnaires